Menu
Not yet recruiting NCT07113184

Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke

No phase Interventional Acute Ischemic Stroke

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: dual sr, single sr.
Who it may be relevant to
Registry conditions: Acute Ischemic Stroke. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

DUAL VERSUS SINGLE STENTRIEVER FOR RECANALIZATION IN ACUTE ISCHEMIC STROKE: THE RANDOMIZED DOUBLE UP TRIAL

Overview

This study seeks to provide high-quality evidence on the potential benefits of the dual stentriever approach, potentially informing future clinical guidelines and improving outcomes in patients with anterior circulation large vessel occlusion strokes.

Interventions

  • Device dual sr
    Dual Stentriever
  • Device single sr
    Single Stentriever

Primary outcome measures

  • Time takes in achieving complete reperfusion after a single thrombectomy pass. [Time frame: 24 hours or 48 hours after thrombectomy]

Eligibility criteria

Inclusion criteria

  • Age ≥ 18
  • NIHSS ≥ 6
  • mRS ≤ 1
  • Proximal anterior circulation occlusion
  • ASPECTS > 6
  • Informed consent

Exclusion criteria

  • Absence of occlusion
  • Posterior circulation stroke
  • Carotid dissection or tandem stenosis requiring treatment
  • Severe comorbidities or contraindications to imaging contrast

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Spain · 3 centers
  • Hospital de Burgos — Burgos
  • Complejo Hospitalario de Salamanca — Salamanca
  • Hospital universitario marques de valdecilla — Santander

Identifiers

NCT: NCT07113184 · DOBLE UP

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗